Baxion
Screening
Tags
Alerts
Theme
Gossamer Bio, Inc.
GOSS
·
NASDAQ
·
$0.22
Share Price as of 11/2
·
$52M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/13/26
10-Q
Q1 ended 03/31/26
05/15/26
10-K
FY 2025
03/17/26
10-Q
Q3 ended 09/30/25
11/05/25
10-Q
Q2 ended 06/30/25
08/05/25
Disclosures
Filter
8-K
Current report
10/28/26
8-K
Current report
09/28/26
8-K
Current report
09/23/26
8-K
Current report
09/16/26
8-K
Current report
09/11/26
Prospectuses and Registrations
Filter
POS AM
Post-effective amendment
03/17/26
POSASR
Prospectus / registration
03/17/26
S-3ASR
Automatic shelf registration
01/28/26
S-8
Registration of securities for employees
03/13/25
S-8
Registration of securities for employees
03/05/24
Proxies
Filter
DEF 14A
Definitive proxy
09/16/26
PRE 14A
Preliminary proxy
09/03/26
DEF 14A
Definitive proxy
06/09/26
DEFA14A
Additional proxy materials
05/18/26
PRE 14A
Preliminary proxy
05/18/26
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
10/29/26
SC 13D/A
Beneficial ownership (amended)
10/08/26
SC 13D/A
Beneficial ownership (amended)
09/28/26
Form 4
Insider transaction
09/25/26
Form 4
Insider transaction
09/25/26
Other
Filter
D
D
09/04/26
ARS
Annual report to shareholders
04/24/26
EFFECT
Request for effectiveness
03/18/26
ARS
Annual report to shareholders
04/29/25
ARS
Annual report to shareholders
04/26/24
Latest Filings
Filter
8-K
Current report
10/28/26
8-K
Current report
09/28/26
8-K
Current report
09/23/26
8-K
Current report
09/16/26
DEF 14A
Definitive proxy
09/16/26
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
10/29/26
SC 13D/A
Beneficial ownership (amended)
10/08/26
SC 13D/A
Beneficial ownership (amended)
09/28/26
Form 4
Insider transaction
09/25/26
Form 4
Insider transaction
09/25/26